PP-1002

N/A

Report date: 2025/01/26 15:54:33

Base Information

Drug NamePP-1002
Drug Alias Nameanti-Escherichia coli bacteriophage (Pherecydes Pharma/BIOASTER)PP-1002
ClassificationBiologics > Bacteriophages
Mechanisms of ActionAntibacterial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionUrinary Tract InfectionsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPherecydes Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPherecydes PharmaBioaster Technology Research Institute
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionUrinary Tract InfectionsEscherichia coli Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A